AVEO PHARMACEUTICALS, INC. - FORM 10-K - EX-32.2 - CERTIFICATION OF PFO PURSUANT TO SECTION 906 - March 11, 2011

Attached files

file filename
10-K - FORM 10-K - AVEO PHARMACEUTICALS, INC.d10k.htm
EX-10.8 - FORM OF RESTRICTED STOCK AGREEMENT - AVEO PHARMACEUTICALS, INC.dex108.htm
EX-10.19 - CONSULTATION AND SCIENTIFIC ADVISORY BOARD AGREEMENT - AVEO PHARMACEUTICALS, INC.dex1019.htm
EX-21.1 - SUBSIDIARIES OF THE REGISTRANT - AVEO PHARMACEUTICALS, INC.dex211.htm
EX-31.2 - CERTIFICATION OF PFO PURSUANT TO SECTION 302 - AVEO PHARMACEUTICALS, INC.dex312.htm
EX-23.1 - CONSENT OF ERNST & YOUNG LLP - AVEO PHARMACEUTICALS, INC.dex231.htm
EX-31.1 - CERTIFICATION OF PEO PURSUANT TO SECTION 302 - AVEO PHARMACEUTICALS, INC.dex311.htm
EX-32.1 - CERTIFICATION OF PEO PURSUANT TO SECTION 906 - AVEO PHARMACEUTICALS, INC.dex321.htm
EX-10.30 - COLLABORATION AND LICENSE AGREEMENT - AVEO PHARMACEUTICALS, INC.dex1030.htm

EXHIBIT 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report on Form 10-K of AVEO Pharmaceuticals, Inc. (the “Company”) for the fiscal year ended December 31, 2010 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, David Johnston, Chief Financial Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, that, to his knowledge on the date hereof:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: March 11, 2011

 

/s/ David B. Johnston

David B. Johnston

Chief Financial Officer

AVEO PHARMACEUTICALS, INC. Reports